BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15367651)

  • 21. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
    Ye M; Morello CS; Spector DH
    J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus.
    Marques S; Alenquer M; Stevenson PG; Simas JP
    PLoS Pathog; 2008 Oct; 4(10):e1000177. PubMed ID: 18846211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.
    Hassett DE; Zhang J; Slifka M; Whitton JL
    J Virol; 2000 Mar; 74(6):2620-7. PubMed ID: 10684276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.
    Hung CF; Tsai YC; He L; Wu TC
    Mol Ther; 2007 Jun; 15(6):1211-9. PubMed ID: 17356542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
    Jayakumar A; Castilho TM; Park E; Goldsmith-Pestana K; Blackwell JM; McMahon-Pratt D
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1204. PubMed ID: 21695103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
    Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine protection against murid herpesvirus-4 is maintained when the priming virus lacks known latency genes.
    Lawler C; Simas JP; Stevenson PG
    Immunol Cell Biol; 2020 Jan; 98(1):67-78. PubMed ID: 31630452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.
    Argilaguet JM; Pérez-Martín E; Nofrarías M; Gallardo C; Accensi F; Lacasta A; Mora M; Ballester M; Galindo-Cardiel I; López-Soria S; Escribano JM; Reche PA; Rodríguez F
    PLoS One; 2012; 7(9):e40942. PubMed ID: 23049728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.
    Stevenson PG; Simas JP; Efstathiou S
    J Gen Virol; 2009 Oct; 90(Pt 10):2317-2330. PubMed ID: 19605591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.
    Usherwood EJ; Roy DJ; Ward K; Surman SL; Dutia BM; Blackman MA; Stewart JP; Woodland DL
    J Exp Med; 2000 Oct; 192(7):943-52. PubMed ID: 11015436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.
    Dekhtiarenko I; Ratts RB; Blatnik R; Lee LN; Fischer S; Borkner L; Oduro JD; Marandu TF; Hoppe S; Ruzsics Z; Sonnemann JK; Mansouri M; Meyer C; Lemmermann NA; Holtappels R; Arens R; Klenerman P; Früh K; Reddehase MJ; Riemer AB; Cicin-Sain L
    PLoS Pathog; 2016 Dec; 12(12):e1006072. PubMed ID: 27977791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.
    Vojnov L; Bean AT; Peterson EJ; Chiuchiolo MJ; Sacha JB; Denes FS; Sandor M; Fuller DH; Fuller JT; Parks CL; McDermott AB; Wilson NA; Watkins DI
    Vaccine; 2011 Oct; 29(43):7483-90. PubMed ID: 21839132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
    López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
    PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.
    Jennings RN; Grayson JM; Barton ES
    J Virol; 2014 Dec; 88(24):14040-9. PubMed ID: 25253356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens.
    Gredmark-Russ S; Cheung EJ; Isaacson MK; Ploegh HL; Grotenbreg GM
    J Virol; 2008 Dec; 82(24):12205-12. PubMed ID: 18922872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.